Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BRSK1 antisense RNA 1 (BRSK1-AS1) is a long non-coding RNA gene located antisense to the BRSK1 protein-coding gene. Its primary molecular classification is as an antisense RNA, meaning it is transcribed from the DNA strand opposite to BRSK1 and may regulate BRSK1 or neighboring genes through RNA interference, chromatin modification, or other antisense mechanisms[6][9]. There is no specific published evidence connecting BRSK1-AS1 to disease, clinical biomarker roles, or direct therapeutic intervention. Its full functional relevance in human biology remains to be formally characterized.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BRSK1 antisense RNA 1 (BRSK1-AS1).